22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › BALCHEM CORP. › 2024-2025

BALCHEM CORP. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and BALCHEM CORP.’s Form 8-K, filed June 20, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Ballot items
  • 388Asset managers, any item
  • 2,267Fund votes
  • June 18, 2025Meeting date

Results at a glance

Meeting of June 18, 2025: 5 items on BALCHEM CORP.’s Form 8-K, filed June 20, 2025: 5 passed (calculated).

Dissent

No notable dissent.

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore BALCHEM CORP. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by BALCHEM CORP.

These tallies are BALCHEM CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 20, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BALCHEM CORP. — official shareholder meeting results, meeting held June 18, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Theodore L. Harris 24,963,4071,262,838963,019 --2,204,153 95%Passed (calculated)—
Elect Director: Monica Vicente 26,452,293718,53118,440 --2,204,153 97%Passed (calculated)—
Elect Director: Matthew Wineinger 26,132,8611,037,42118,982 --2,204,153 96%Passed (calculated)—
2. The ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 28,863,261522,3547,802 ---- 98%Passed (calculated)—
3. Advisory approval of the compensation of the Company's named executive officers 25,454,8631,685,14349,258 --2,204,153 94%Passed (calculated)—

Source: BALCHEM CORP., Form 8-K, filed with the SEC on June 20, 2025 — read the filing on EDGAR.

How asset managers voted at the BALCHEM CORP. 2024-2025 meeting

388 asset managers disclosed a vote on at least one BALCHEM CORP. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Theodore L. Harris

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 24,963,407AGAINST: 1,262,838
Details: description as filed, official tally, votes by 111 asset managers

Description as filed by funds: Election of Directors: Theodore L. Harris

BALCHEM CORP.’s own tally for this item (“Elect Director: Theodore L. Harris”): 24,963,407 for, 1,262,838 against, per its Form 8-K filed June 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 14,599,242 for, 199,682 against, 4,336 abstained, 25,068 not voted.

FOR
FOR: 14,599,242AGAINST: 199,682ABSTAIN: 4,336NOT VOTED: 25,068
Largest asset managers voting on “Election of Directors: Theodore L. Harris” at BALCHEM CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,931,6123 00For
BlackRock3,518,1420 00For
Fidelity1,555,5080 00For
CONESTOGA FUNDS762,5650 00For
WASATCH FUNDS TRUST522,8850 00For
State Street452,54018 00For
Charles Schwab344,2430 00For
TIAA285,6440 00For
Legg Mason274,4430 00For
Nationwide264,9400 00For
JPMorgan258,9320 00For
PROFESSIONALLY MANAGED PORTFOLIOS205,0000 00For
Calvert0174,667 00Against
T. Rowe Price171,8700 00For
Columbia Threadneedle170,6650 00For
GMO139,8960 00For
First Trust137,6030 00For
Goldman Sachs136,7240 00For
Bridge Builder Trust117,6180 00For
WILLIAM BLAIR FUNDS99,0400 00For
Equitable95,0370 00For
Tributary Funds, Inc.78,2980 00For
Jackson National78,2250 00For
QUANTITATIVE MASTER SERIES LLC55,6120 00For
SEI54,8410 00For

Showing the 25 largest of 111 asset managers. All 111 are in the interactive database (link above).

Elect Director: Monica Vicente

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 26,452,293AGAINST: 718,531

Prior year: 99.6% for (June 20, 2024 meeting) ▼ 2.2 pts

Details: description as filed, official tally, votes by 111 asset managers

Description as filed by funds: Election of Directors: Monica Vicente

BALCHEM CORP.’s own tally for this item (“Elect Director: Monica Vicente”): 26,452,293 for, 718,531 against, per its Form 8-K filed June 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 14,547,787 for, 251,137 against, 4,336 abstained, 25,068 not voted.

FOR
FOR: 14,547,787AGAINST: 251,137ABSTAIN: 4,336NOT VOTED: 25,068
Largest asset managers voting on “Election of Directors: Monica Vicente” at BALCHEM CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,931,6132 00For
BlackRock3,518,1420 00For
Fidelity1,555,5080 00For
CONESTOGA FUNDS762,5650 00For
WASATCH FUNDS TRUST522,8850 00For
State Street452,5580 00For
Charles Schwab344,2430 00For
TIAA285,6440 00For
Legg Mason274,4430 00For
Nationwide264,9400 00For
JPMorgan258,9320 00For
PROFESSIONALLY MANAGED PORTFOLIOS205,0000 00For
Calvert174,6670 00For
T. Rowe Price0171,870 00Against
Columbia Threadneedle170,6650 00For
GMO139,8960 00For
First Trust137,6030 00For
Goldman Sachs136,7240 00For
Bridge Builder Trust117,6180 00For
WILLIAM BLAIR FUNDS99,0400 00For
Equitable55,57839,459 00Mixed
Tributary Funds, Inc.78,2980 00For
Jackson National78,2250 00For
QUANTITATIVE MASTER SERIES LLC55,6120 00For
SEI54,8410 00For

Showing the 25 largest of 111 asset managers. All 111 are in the interactive database (link above).

Elect Director: Matthew Wineinger

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 26,132,861AGAINST: 1,037,421
Details: description as filed, official tally, votes by 111 asset managers

Description as filed by funds: Election of Directors: Matthew Wineinger

BALCHEM CORP.’s own tally for this item (“Elect Director: Matthew Wineinger”): 26,132,861 for, 1,037,421 against, per its Form 8-K filed June 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 14,538,621 for, 260,303 against, 4,336 abstained, 25,068 not voted.

FOR
FOR: 14,538,621AGAINST: 260,303ABSTAIN: 4,336NOT VOTED: 25,068
Largest asset managers voting on “Election of Directors: Matthew Wineinger” at BALCHEM CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,931,6132 00For
BlackRock3,518,1420 00For
Fidelity1,555,5080 00For
CONESTOGA FUNDS762,5650 00For
WASATCH FUNDS TRUST522,8850 00For
State Street452,5580 00For
Charles Schwab344,2430 00For
TIAA285,6440 00For
Legg Mason274,4430 00For
Nationwide264,9400 00For
JPMorgan258,9320 00For
PROFESSIONALLY MANAGED PORTFOLIOS205,0000 00For
Calvert174,6670 00For
T. Rowe Price0171,870 00Against
Columbia Threadneedle170,6650 00For
GMO139,8960 00For
First Trust137,6030 00For
Goldman Sachs136,7240 00For
Bridge Builder Trust117,6180 00For
WILLIAM BLAIR FUNDS99,0400 00For
Equitable55,57839,459 00Mixed
Tributary Funds, Inc.78,2980 00For
Jackson National78,2250 00For
QUANTITATIVE MASTER SERIES LLC55,6120 00For
SEI54,8410 00For

Showing the 25 largest of 111 asset managers. All 111 are in the interactive database (link above).

Advisory approval of the compensation of the Company's named executive officers

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 14 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 25,454,863AGAINST: 1,685,143

Prior year: 97.1% for (June 20, 2024 meeting) ▼ 3.3 pts

Details: description as filed, official tally, votes by 388 asset managers

Description as filed by funds: Advisory approval of the compensation of the Company's named executive officers.

BALCHEM CORP.’s own tally for this item (“3. Advisory approval of the compensation of the Company's named executive officers”): 25,454,863 for, 1,685,143 against, per its Form 8-K filed June 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 109 asset managers voting on “Advisory approval of the compensation of the Company's named executive officers.” at BALCHEM CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,931,6132 00For
BlackRock3,518,1420 00For
Fidelity1,555,5080 00For
CONESTOGA FUNDS762,5650 00For
WASATCH FUNDS TRUST522,8850 00For
State Street452,5580 00For
Charles Schwab344,2430 00For
TIAA285,6440 00For
Legg Mason274,4430 00For
Nationwide264,9400 00For
JPMorgan258,9320 00For
PROFESSIONALLY MANAGED PORTFOLIOS205,0000 00For
Calvert0174,667 00Against
T. Rowe Price171,8700 00For
Columbia Threadneedle170,6650 00For
GMO139,8960 00For
First Trust137,6030 00For
Goldman Sachs136,7240 00For
Bridge Builder Trust117,6180 00For
WILLIAM BLAIR FUNDS99,0400 00For
Equitable95,0370 00For
Tributary Funds, Inc.78,2980 00For
Jackson National78,2250 00For
QUANTITATIVE MASTER SERIES LLC55,6120 00For
SEI54,8410 00For

Fund voting reports, all 109 managers: 14,622,125 for, 176,241 against, 4,336 abstained, 25,068 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 307 asset managers voting on “Advisory approval of the compensation of the Company's named executive officers.” at BALCHEM CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,197,715281 00For
State Street1,096,3840 00For
GEODE CAPITAL MANAGEMENT, LLC964,2840 00For
APG Asset Management US Inc.0947,925 00Against
WASATCH ADVISORS LP762,8150 00For
GENEVA CAPITAL MANAGEMENT LLC762,7850 00For
Fidelity677,9950 00For
JPMorgan417,4760 00For
SCHRODER INVESTMENT MANAGEMENT GROUP410,3270 00For
Charles Schwab379,0560 00For
Conestoga Capital Advisors, LLC364,0730 00For
Northern Trust354,7800 00For
Clearbridge Investments, LLC337,6440 00For
CONGRESS ASSET MANAGEMENT CO309,3520 00For
Nuveen288,9540 00For
T. Rowe Price254,6330 00For
Stephens Investment Management Group LLC248,6070 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC236,7260 00For
MELLON INVESTMENTS Corp222,7120 00For
GW&K Investment Management, LLC4,7620 00For
SEGALL BRYANT & HAMILL, LLC200,0080 00For
Calvert0188,960 00Against
Grantham, Mayo, Van Otterloo & Co. LLC176,4410 00For
PRINCIPAL GLOBAL INVESTORS170,0390 00For
ATLANTA CAPITAL MANAGEMENT CO L L C139,5010 00For

Institutional-manager reports, all 307 managers: 13,311,570 for, 1,398,052 against, 1,008 abstained, 287 not voted, 212,277 mixed. Showing the 25 largest; every one is in the interactive database (link above).

The ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 28,863,261AGAINST: 522,354

Prior year: 98.2% for (June 20, 2024 meeting) unchanged

Details: description as filed, official tally, votes by 111 asset managers

Description as filed by funds: Ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year 2025.

BALCHEM CORP.’s own tally for this item (“2. The ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 28,863,261 for, 522,354 against, per its Form 8-K filed June 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 14,774,577 for, 24,347 against, 4,336 abstained, 25,068 not voted.

FOR
FOR: 14,774,577AGAINST: 24,347ABSTAIN: 4,336NOT VOTED: 25,068
Largest asset managers voting on “Ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm f” at BALCHEM CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,929,1232,492 00For
BlackRock3,518,1420 00For
Fidelity1,555,5080 00For
CONESTOGA FUNDS762,5650 00For
WASATCH FUNDS TRUST522,8850 00For
State Street452,52533 00For
Charles Schwab344,2430 00For
TIAA285,6440 00For
Legg Mason274,4430 00For
Nationwide264,9400 00For
JPMorgan258,9320 00For
PROFESSIONALLY MANAGED PORTFOLIOS205,0000 00For
Calvert174,6670 00For
T. Rowe Price171,8700 00For
Columbia Threadneedle170,6650 00For
GMO139,8960 00For
First Trust137,6030 00For
Goldman Sachs136,7240 00For
Bridge Builder Trust117,6180 00For
WILLIAM BLAIR FUNDS99,0400 00For
Equitable95,0370 00For
Tributary Funds, Inc.78,2980 00For
Jackson National78,2250 00For
QUANTITATIVE MASTER SERIES LLC55,6120 00For
SEI54,8410 00For

Showing the 25 largest of 111 asset managers. All 111 are in the interactive database (link above).

Largest BALCHEM CORP. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 32,611,544 shares outstanding at the time of that meeting.

Fund voting reports: top BALCHEM CORP. shareholders by shares voted on “Advisory approval of the compensation of the Company's named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 12.06%
2BlackRock 10.79%
3Fidelity 4.77%
4CONESTOGA FUNDS 2.34%
5WASATCH FUNDS TRUST 1.60%
6State Street 1.39%
7Charles Schwab 1.06%
8TIAA 0.88%
9Legg Mason 0.84%
10Nationwide 0.81%
Institutional-manager reports: top BALCHEM CORP. shareholders by shares voted on “Advisory approval of the compensation of the Company's named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 3.67%
2State Street 3.36%
3GEODE CAPITAL MANAGEMENT, LLC 2.96%
4APG Asset Management US Inc. 2.91%
5WASATCH ADVISORS LP 2.34%
6GENEVA CAPITAL MANAGEMENT LLC 2.34%
7Fidelity 2.08%
8JPMorgan 1.28%
9SCHRODER INVESTMENT MANAGEMENT GROUP 1.26%
10Charles Schwab 1.16%

Reported BALCHEM CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

BALCHEM CORP. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock5,047,435 15.48%Form 13F, quarter ended March 31, 2025
Vanguard Group3,850,286 11.81%Form 13F, quarter ended March 31, 2025
Vanguard Portfolio Management2,221,969 6.81%Schedule 13G, filed April 28, 2026
State Street1,227,455 3.76%Form 13F, quarter ended March 31, 2025
APG Asset Management US Inc.1,201,674 3.68%Schedule 13G, filed May 14, 2025
Morgan Stanley782,525 2.40%Form 13F, quarter ended March 31, 2025
FMR (Fidelity)685,348 2.10%Form 13F, quarter ended March 31, 2025
Dimensional Fund Advisors593,749 1.82%Form 13F, quarter ended March 31, 2025
JPMorgan Chase479,737 1.47%Form 13F, quarter ended March 31, 2025
Northern Trust399,033 1.22%Form 13F, quarter ended March 31, 2025

Percentages above are of 32,611,544 shares outstanding, as reported by BALCHEM CORP. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At BALCHEM CORP.'s shareholder meeting held June 18, 2025, in the 2024-2025 proxy season, 388 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 2,267 separate fund positions. On the most widely held item on that ballot — Advisory approval of the compensation of the Company's named executive officers. — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BALCHEM CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 20, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BALCHEM CORP.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

BALCHEM CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “BALCHEM (BCPC) 2025 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/balchem-corp/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.